Aneuploidy as a promoter and suppressor of malignant growth A Vasudevan, KM Schukken, EL Sausville, V Girish, OA Adebambo, ... Nature Reviews Cancer 21 (2), 89-103, 2021 | 131 | 2021 |
CIN and aneuploidy: different concepts, different consequences KM Schukken, F Foijer BioEssays 40 (1), 1700147, 2018 | 71 | 2018 |
Oncogene-like addiction to aneuploidy in human cancers V Girish, AA Lakhani, SL Thompson, CM Scaduto, LM Brown, ... Science 381 (6660), eadg4521, 2023 | 57 | 2023 |
Extensive protein dosage compensation in aneuploid human cancers KM Schukken, JM Sheltzer Genome research 32 (7), 1254-1270, 2022 | 56 | 2022 |
Altering microtubule dynamics is synergistically toxic with spindle assembly checkpoint inhibition KM Schukken, YC Lin, PL Bakker, M Schubert, SF Preuss, JE Simon, ... Life science alliance 3 (2), 2020 | 24 | 2020 |
Aneuploidy in stem cells J Garcia-Martinez, B Bakker, KM Schukken, JE Simon, F Foijer World journal of stem cells 8 (6), 216, 2016 | 15 | 2016 |
Oncogene-like addiction to aneuploidy in human cancers. Science 381, eadg4521 V Girish, AA Lakhani, SL Thompson, CM Scaduto, LM Brown, ... | 6 | 2023 |
Acute systemic loss of Mad2 leads to intestinal atrophy in adult mice KM Schukken, Y Zhu, PL Bakker, MH Koster, L Harkema, SA Youssef, ... Scientific Reports 11 (1), 68, 2021 | 3 | 2021 |
The consequences of aneuploidy and chromosome instability: survival, cell death and cancer KM Schukken | 1 | 2020 |
Altering microtubule dynamics is synergistically toxic with inhibition of the spindle checkpoint KM Schukken, YC Lin, M Schubert, SF Preuss, JE Simon, H van den Bos, ... bioRxiv, 706077, 2019 | | 2019 |